Skip to main content
logo
Colinz Laboratories Limited (BOM:531210)
India flag India · Delayed Price · Currency is INR
80.72
+0.85 (1.06%)
At close: Aug 17, 2026

Colinz Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
58.1161.3665.2870.371.5569.74
Revenue Growth
-8.45%-6.00%-7.14%-1.75%2.59%13.24%
Gross Profit
42.7844.2643.8745.8447.6146.01
Operating Income
1.782.513.644.135.043.85
Net Income
27.975.154.974.874.573.39
Earnings Per Share
11.112.041.971.931.820.74
EPS Growth
484.71%3.55%2.07%6.04%145.95%64.44%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
85.2985.2955.57057.2952.06
Total Debt
3.93.96.415.72.734.85
Net Cash (Debt)
81.3981.3949.0964.354.5547.22
Net Cash Growth
65.79%65.79%-23.65%17.87%15.54%28.00%
Net Cash Per Share
32.3332.2719.4825.5021.7110.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-25.41-14.5410.354.034.67
Capital Expenditures
---2.62---0.38
Free Cash Flow
-25.41-17.1610.354.034.3
Free Cash Flow Growth
---156.84%-6.21%-78.52%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
73.63%72.13%67.21%65.21%66.54%65.97%
Operating Margin
3.06%4.09%5.58%5.87%7.04%5.52%
Pretax Margin
59.02%11.23%9.49%9.25%8.38%6.89%
Profit Margin
48.13%8.38%7.61%6.92%6.39%4.87%
FCF Margin
-41.41%-26.28%14.72%5.63%6.16%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
7.2721.7936.7519.4334.9831.73
P/FCF Ratio
8.004.41-9.1439.7125.06
PS Ratio
3.501.832.801.352.241.54